| ||
Oxford
I-BRD9
Professor Chas Bountra on BBC Radio
Chas Bountra, SGC Oxford’s Chief Scientist and Professor of Translational Medicine at the University of Oxford, is a guest on Will Gompertz’s BBC radio show to discuss how SGC and Oxford scientists are contributing to the development of new and affordable medicines for diseases such as dementia.
http://www.bbc.co.uk/programmes/p02q9w8w (interview starts at 1:08:52)
Frontiers in Integral Membrane Protein Structural Biology
BI-9564
Structure of the TREK-2 ion channel shows how nerves sense touch and respond to drugs
GSK484
How the SGC in Oxford is working to cure a devastating rare disease
Fibrodysplasia ossificans progressiva (FOP) is one of the rarest and most disabling genetic conditions known. The University of Oxford is one of the few places in the world where this disease is being researched, with support from donations.
GMEC/Pfizer Rare Disease Collaboration: First Projects Signed
GMEC is pleased to announce the signing of the first collaborative research projects to be launched under theGMEC/Pfizer Rare Diseases agreement which was announced in 2014. |
Alzheimer's: £30m dementia research alliance launched
A new Drug Discovery Institute in Oxford focusing on finding new medicines for Azheimer’s is being funded by Alzheimer’s Research UK. The SGC will play a major role in this Institute, providing our expertise in protein production, protein crystallography and medicinal chemistry. Read more: |